The patient experience of Raynaud's phenomenon in systemic sclerosis

John D Pauling; Lesley Ann Saketkoo; Marco Matucci-Cerinic; Francesca Ingegnoli; Dinesh Khanna

doi:10.1093/rheumatology/key026

The patient experience of Raynaud's phenomenon in systemic sclerosis

John D Pauling, Lesley Ann Saketkoo, Marco Matucci-Cerinic, Francesca Ingegnoli, Dinesh Khanna

Department of Life Sciences

Research output: Contribution to journal › Review article › peer-review

42 Citations (SciVal)

82 Downloads (Pure)

Abstract

RP is the most common manifestation of SSc and a major cause of disease-related morbidity. This review provides a detailed appraisal of the patient experience of SSc-RP and potential implications for disease classification, patient-reported outcome instrument development and SSc-RP clinical trial design. The review explores the clinical features of SSc-RP, the severity and burden of SSc-RP symptoms and the impact of SSc-RP on function, work and social participation, body image dissatisfaction and health-related quality of life in SSc. Where management of SSc-RP is concerned, the review focuses on the 'patient experience' of interventions for SSc-RP, examining geographic variation in clinical practice and potential barriers to the adoption of treatment recommendations concerning best-practice management of SSc-RP. Knowledge gaps are highlighted that could form the focus of future research. A more thorough understanding of the patient experience could support the development of novel reported outcome instruments for assessing SSc-RP.

Original language	English
Article number	key026
Pages (from-to)	18-26
Number of pages	9
Journal	Rheumatology
Volume	58
Issue number	1
Early online date	12 Mar 2018
DOIs	https://doi.org/10.1093/rheumatology/key026
Publication status	Published - 1 Jan 2019

Keywords

Disability
Function
Health-related quality of life
Impact
Patient experience
Raynaud's phenomenon
Systemic sclerosis
Humans
Male
Social Participation/psychology
Body Image/psychology
Quality of Life
Adult
Female
Scleroderma, Systemic/complications
Raynaud Disease/etiology

ASJC Scopus subject areas

Pharmacology (medical)
Rheumatology

Access to Document

10.1093/rheumatology/key026

1366.R1_Accepted_Manuscript
This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of recordJohn D Pauling, Lesley Ann Saketkoo, Marco Matucci-Cerinic, Francesca Ingegnoli, Dinesh Khanna; The patient experience of Raynaud’s phenomenon in systemic sclerosis, Rheumatology, key026, is available online at: https://doi.org/10.1093/rheumatology/key026.
Accepted author manuscript, 501 KB

Cite this

@article{c93e3a3aa0924cecb74de2a7bb074abf,

title = "The patient experience of Raynaud's phenomenon in systemic sclerosis",

abstract = "RP is the most common manifestation of SSc and a major cause of disease-related morbidity. This review provides a detailed appraisal of the patient experience of SSc-RP and potential implications for disease classification, patient-reported outcome instrument development and SSc-RP clinical trial design. The review explores the clinical features of SSc-RP, the severity and burden of SSc-RP symptoms and the impact of SSc-RP on function, work and social participation, body image dissatisfaction and health-related quality of life in SSc. Where management of SSc-RP is concerned, the review focuses on the 'patient experience' of interventions for SSc-RP, examining geographic variation in clinical practice and potential barriers to the adoption of treatment recommendations concerning best-practice management of SSc-RP. Knowledge gaps are highlighted that could form the focus of future research. A more thorough understanding of the patient experience could support the development of novel reported outcome instruments for assessing SSc-RP.",

keywords = "Disability, Function, Health-related quality of life, Impact, Patient experience, Raynaud's phenomenon, Systemic sclerosis, Humans, Male, Social Participation/psychology, Body Image/psychology, Quality of Life, Adult, Female, Scleroderma, Systemic/complications, Raynaud Disease/etiology",

author = "Pauling, {John D} and Saketkoo, {Lesley Ann} and Marco Matucci-Cerinic and Francesca Ingegnoli and Dinesh Khanna",

year = "2019",

month = jan,

day = "1",

doi = "10.1093/rheumatology/key026",

language = "English",

volume = "58",

pages = "18--26",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - The patient experience of Raynaud's phenomenon in systemic sclerosis

AU - Pauling, John D

AU - Saketkoo, Lesley Ann

AU - Matucci-Cerinic, Marco

AU - Ingegnoli, Francesca

AU - Khanna, Dinesh

PY - 2019/1/1

Y1 - 2019/1/1

N2 - RP is the most common manifestation of SSc and a major cause of disease-related morbidity. This review provides a detailed appraisal of the patient experience of SSc-RP and potential implications for disease classification, patient-reported outcome instrument development and SSc-RP clinical trial design. The review explores the clinical features of SSc-RP, the severity and burden of SSc-RP symptoms and the impact of SSc-RP on function, work and social participation, body image dissatisfaction and health-related quality of life in SSc. Where management of SSc-RP is concerned, the review focuses on the 'patient experience' of interventions for SSc-RP, examining geographic variation in clinical practice and potential barriers to the adoption of treatment recommendations concerning best-practice management of SSc-RP. Knowledge gaps are highlighted that could form the focus of future research. A more thorough understanding of the patient experience could support the development of novel reported outcome instruments for assessing SSc-RP.

AB - RP is the most common manifestation of SSc and a major cause of disease-related morbidity. This review provides a detailed appraisal of the patient experience of SSc-RP and potential implications for disease classification, patient-reported outcome instrument development and SSc-RP clinical trial design. The review explores the clinical features of SSc-RP, the severity and burden of SSc-RP symptoms and the impact of SSc-RP on function, work and social participation, body image dissatisfaction and health-related quality of life in SSc. Where management of SSc-RP is concerned, the review focuses on the 'patient experience' of interventions for SSc-RP, examining geographic variation in clinical practice and potential barriers to the adoption of treatment recommendations concerning best-practice management of SSc-RP. Knowledge gaps are highlighted that could form the focus of future research. A more thorough understanding of the patient experience could support the development of novel reported outcome instruments for assessing SSc-RP.

KW - Disability

KW - Function

KW - Health-related quality of life

KW - Impact

KW - Patient experience

KW - Raynaud's phenomenon

KW - Systemic sclerosis

KW - Humans

KW - Male

KW - Social Participation/psychology

KW - Body Image/psychology

KW - Quality of Life

KW - Adult

KW - Female

KW - Scleroderma, Systemic/complications

KW - Raynaud Disease/etiology

UR - http://www.scopus.com/inward/record.url?scp=85046847556&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/key026

DO - 10.1093/rheumatology/key026

M3 - Review article

C2 - 29538754

SN - 1462-0324

VL - 58

SP - 18

EP - 26

JO - Rheumatology

JF - Rheumatology

IS - 1

M1 - key026

ER -

The patient experience of Raynaud's phenomenon in systemic sclerosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this